Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5076587
Max Phase: Preclinical
Molecular Formula: C74H114N20O16S2
Molecular Weight: 1603.98
Molecule Type: Unknown
Associated Items:
ID: ALA5076587
Max Phase: Preclinical
Molecular Formula: C74H114N20O16S2
Molecular Weight: 1603.98
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCC[C@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2
Standard InChI: InChI=1S/C74H114N20O16S2/c1-8-11-26-46-60(98)82-47(27-18-31-79-73(75)76)61(99)83-48(28-19-32-80-74(77)78)62(100)88-53-39-112-111-38-52(66(104)86-50(36-45-24-16-13-17-25-45)64(102)85-49(63(101)84-46)35-44-22-14-12-15-23-44)89-69(107)56(40(4)9-2)90-68(106)54-29-20-33-93(54)71(109)55-30-21-34-94(55)72(110)57(41(5)10-3)91-65(103)51(37-95)87-59(97)42(6)81-70(108)58(43(7)96)92-67(53)105/h12-17,22-25,40-43,46-58,95-96H,8-11,18-21,26-39H2,1-7H3,(H,81,108)(H,82,98)(H,83,99)(H,84,101)(H,85,102)(H,86,104)(H,87,97)(H,88,100)(H,89,107)(H,90,106)(H,91,103)(H,92,105)(H4,75,76,79)(H4,77,78,80)/t40-,41-,42+,43+,46+,47+,48-,49+,50+,51-,52-,53-,54-,55-,56-,57-,58-/m0/s1
Standard InChI Key: JGHSBAPYWVMHHA-BBFAPANISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1603.98 | Molecular Weight (Monoisotopic): 1602.8163 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Muratspahić E, Tomašević N, Koehbach J, Duerrauer L, Hadžić S, Castro J, Schober G, Sideromenos S, Clark RJ, Brierley SM, Craik DJ, Gruber CW.. (2021) Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain., 64 (13.0): [PMID:34162205] [10.1021/acs.jmedchem.1c00158] |
Source(1):